Evidence map›Paper›PMID 34019915›Full record

ArticlePharmacology, biochemistry, and behavior2021

Nicotine-free vapor inhalation produces behavioral disruptions and anxiety-like behaviors in mice: Effects of puff duration, session length, sex, and flavor.

Patrick I Garrett, Sarah C Honeycutt, Clarissa Marston, Nicole Allen, Allyson G Barraza, Megan Dewey, Breeann Turner, Ashley M Peterson, Todd M Hillhouse

Open access · greenAbstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Patrick I GarrettNeuroscience Graduate Program, University of Wyoming, Laramie, WY, USA; Department of Psychological Science, Weber State University, Ogden, UT, USA.
Sarah C HoneycuttDepartment of Psychology, University at Buffalo, Buffalo, NY, USA; Department of Psychological Science, Weber State University, Ogden, UT, USA.
Clarissa MarstonDepartment of Psychological Science, Weber State University, Ogden, UT, USA.
Nicole AllenDepartment of Psychological Science, Weber State University, Ogden, UT, USA.
Allyson G BarrazaDepartment of Psychological Science, Weber State University, Ogden, UT, USA.
Megan DeweyDepartment of Psychological Science, Weber State University, Ogden, UT, USA.
Breeann TurnerDepartment of Psychological Science, Weber State University, Ogden, UT, USA.
Ashley M PetersonDepartment of Psychological Science, Weber State University, Ogden, UT, USA.
Todd M HillhouseDepartment of Psychological Science, Weber State University, Ogden, UT, USA; Department of Psychology, University of Wisconsin Green Bay, Green Bay, WI, USA. Electronic address: hillhout@uwgb.edu.
Weber State University · USUniversity of Wisconsin–Green Bay · US

Funding

RESEARCH TRAINING ON ALCOHOL ETIOLOGY AND TREATMENTT32AA007583 · NIAAA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Gregory G Homish, Jennifer P Read · 2000 to 2026
$8.5M
NIAAA NIH HHS T32 AA007583
6 · The paper itself

Abstract

Electronic-cigarette's (ECIGs) popularity has grown over the last decade and changed the way individuals administer nicotine. Preclinical research is imperative for understanding the addictive properties and health-risks associated with ECIG use; however, there is not a standard dosing regimen used across research laboratories. The main objective was to determine how vapor puff durations, administration session length, and flavored e-liquid alter general and mood-disorder related behaviors while providing a foundation of vapor administration parameters. Adult male and female C57BL/6 mice were exposed to several nicotine-free unflavored vapor puff durations (1, 3, 6, or 10 s) and vapor administration session lengths (10 and 30 min) then measured on the following assays: locomotor activity (LMA), tail suspension test (TST), and light-dark test. The effects of mecamylamine and the time-course of vapor-induced depression of LMA also were assessed. Additionally, mice were exposed to flavored (strawberry and adventurers tobacco blend) vapor inhalation and measured on locomotor activity, tail suspension test, and light-dark test. Following both 10 and 30 min vapor administration session, there was a puff duration-dependent decrease in distance traveled, time in center, and rearing. The vapor-induced depression of LMA was not mediated by nicotine or nicotinic acetylcholine receptor (nAChR) activation and lasted 60-90 min. The 10 s puff duration produced an anxiogenic-like effect in the light-dark test by decreasing the time spent in the light side. Vapor inhalation did not significantly alter TST behavior. No significant effects of sex or flavor were found. The anxiogenic-like effects of nicotine-free vapor inhalation are concerning as many adolescents vape nicotine-free flavored e-liquid, and there is an association between ECIGs and mood disorders. Additionally, these studies demonstrate that vapor puff duration, but not vapor administration session length, is an important variable to consider during research design as it can become a confounding variable and alter baseline behaviors.

Indexed as

Electronic Nicotine Delivery SystemsAdministration, InhalationAdolescentAnimalsAnxietyBehavior, AnimalE-Cigarette VaporFemaleFlavoring AgentsHumansLocomotionMaleMecamylamineMiceMice, Inbred C57BLNicotineE-Cigarette VaporFlavoring AgentsMecamylamineNicotineNicotinic AntagonistsReceptors, NicotinicAnxietyElectronic-cigarettes (ECIGs)ENDSMiceSex differencesVape

Identifiers

PMID34019915
PMCPMC9731367
OpenAlexW3163291248

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.